The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
AACR 2023 | Early detection and interception in lung cancer
David Carbone, MD, PhD, The Ohio State University Comprehensive Cancer Center, Columbus, OH, talks on the need for early detection in patients with lung cancer, where detection and management incidental nodule in the lungs are inadequate. Prof. Carbone additionally highlights the link between air pollution and rates of EGFR-mutant lung cancer in never-smoker patients. This interview took place at the American Association for Cancer Research (AACR) Annual Meeting 2023 in Orlando, FL.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
